Bristol-Myers has announced that the FDA finally bestowed them the green light for their melanoma drug combo. With this, patients may soon have a new treatment option to improve their clinical outcomes.
Bristol-Myers has announced that the FDA finally bestowed them the green light for their melanoma drug combo. With this, patients may soon have a new treatment option to improve their clinical outcomes.
Share this Article
Recommended